← All stocks

Black Diamond Therapeutics, Inc.

BDTX No buying or selling

CIK 0001701541 #4227 in the set updated 19 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

$0.00

$0.00 against sales at will

By person

9 insiders · 0 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

BIOTECH GROWTH N V

10% owner

—

2,733,547

$5.79M

−67.9%

Buck Elizabeth

CHIEF SCIENTIFIC OFFICER

—

170,192

$360.28K

+78.8%

Velleca Mark A.

PRESIDENT & CEO

—

121,522

$257.25K

+161.2%

Behbahani Ali

Director

—

102,529

$217.04K

+87.9%

Jones Erika

SEE REMARKS

—

85,150

$180.25K

+738.9%

Hatzis-Schoch Brent

SEE REMARKS

—

83,400

$176.55K

+892.9%

Yurasov Sergey

CHIEF MEDICAL OFFICER

—

75,000

$158.77K

—

Raman Prakash

Director

—

45,039

$95.34K

+1,857%

Campbell Shannon

Director

—

8,865

$18.77K

+340.8%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 0

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 0

History held since 31 Jan 2020